Offline
| Post a Message | Explore Forums | Browse Stock Messages | Hot Discussions | Top rated Messages | Top Boarders | |
|
|
|
Orchid Chemicals and Pharmaceuticals
NSE Announcements on Orchid Chemical
Posted by :
MMB MessengerTracked by: 0 Boarder
Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that the Allotment Committee of the Board of Directors of the Company at their meeting held on August 29, 2008 have allotted 41,79,000 equity shares of Rs. 10 each at a price of Rs. 202.58 per share pursuant to conversion of warrants by the persons in Promotor/Promotor Group. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). ...
BSE Announcements on Orchid Chemical
Posted by : MMB MessengerTracked by: 0 Boarder
Orchid Chemicals & Pharmaceuticals Ltd has informed BSE that the Allotment Committee of the Board of Directors of the Company at its meeting held on August 29, 2008, have allotted 41,79,000 equity shares of Rs 10 each at a price of Rs 202.58 per share pursuant to conversion of warrants by the following persons in Promoter/Promoter Group:
1. Name of the Allottee - Ms. Divya R
- No. of equity shares - 22,62,500
2. Name of the Allottee - Ms. Sowmya R
- No. of equity shares - 18,81,500
3. Name of the Allottee - Dr. M R Girinath
- No. of equity shares - 35,000
The equity shares allotted would be subject to lock-in till February 28, 2010.
Also, the Allotment Committee of the Board of Directors of the Company at their meeting held on August 29, 2008 have allotted 1500 equity shares of Rs 10 each in favour employees at a price of Rs 193.25 per share under ESOP 2005 Scheme.
The shares allotted under the ESOP scheme would be subject to a lock-in for a period of 1 year from the date of allotment.
Consequent to these allotments, the paid-up capital of the Company has increased from Rs 662,615,760 to Rs 704,420,760....
BSE Announcements on Orchid Chemical
Posted by : MMB MessengerTracked by: 0 Boarder
Orchid Chemicals & Pharmaceuticals Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 20, 2008 to September 29, 2008 (both days inclusive) for the purpose of payment of dividend & Annual General Meeting (AGM) of the Company to be held on September 29, 2008....
NSE Announcements on Orchid Chemical
Posted by : MMB MessengerTracked by: 0 Boarder
Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that the Annual General Meeting of the Company is scheduled to be held on September 29, 2008. Further, the dates of closure of Register of Members for the purpose of Annual General Meeting and for payment of dividend has been fixed by the Board from September 20, 2008 to September 29, 2008 (both days inclusive)....
NSE Announcements on Orchid Chemical
Posted by : MMB MessengerTracked by: 0 Boarder
Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that auditors have conducted the limited review of the Un-audited financial results (provisional) for the quarter ended June 30, 2008. The details of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). ...
NSE Announcements on Orchid Chemical
Posted by : MMB MessengerTracked by: 0 Boarder
Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange that "The Allotment Committee of the Board of Directors of Orchid Chemicals and Pharmaceuticals Limited at their meeting held on August 13, 2008 have allotted 385000 equity share of Rs. 10 each as per particulars given below: (1) 381000 equity shares of Rs. 10 each in favour of R. Sowmya at a price of Rs. 202.58 per share pursuant to conversion of warrants granted to Promoter/Promoter Group. These equity shares would be subject to lock-in till February 28, 2010. (2) 3000 equity shares of Rs. 10 each in favour R. Narayanan, Chairman, at a price of Rs. 200.44 per share under ESOP 1999 Scheme. (3) 1000 equity shares of Rs. 10 each in favour employees at a price of Rs. 193.25 per share under ESOP 2005 Scheme. The shares allotted under the ESOP scheme would be subject to a lock-in for a period of 1 year from the date of allotment. Consequent to this allotment, the paid-up capital of the Company has increased from Rs. 658,765,760 to Rs. 662,615,760"....
BSE Announcements on Orchid Chemical
Posted by : MMB MessengerTracked by: 0 Boarder
Orchid Chemicals & Pharmaceuticals Ltd has informed BSE that the Allotment Committee of the Board of Directors of the Company at it meeting held on August 13, 2008 have allotted 385000 equity share of Rs 10 each as per particulars given below:
- 381000 equity shares of Rs 10 each in favour of R Sowmya at a price of Rs 202.58 per share pursuant to conversion of warrants granted to Promoter / Promoter Group. These equity shares would be subject to lock-in till February 28, 2010.
- 3000 equity shares of Rs 10 each in favour R Narayanan, Chairman, at a price of Rs 200.44 per share under ESOP 1999 Scheme.
- 1000 equity shares of Rs 10 each in favour employees at a price of Rs 193.25 per share under ESOP 2005 Scheme.
The shares allotted under the ESOP scheme would be subject to a lock-in for a period of 1 year from the date of allotment.
Consequent to this allotment, the paid-up capital of the Company has increased from Rs 658,765,760 to Rs 662,615,760....
NSE Announcements on Orchid Chemical
Posted by : MMB MessengerTracked by: 0 Boarder
Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding the press release dated August 13, 2008, titled "Orchid to develop Novel Anticoagulant Drug Candidate from Merck". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements)....
BSE Announcements on Orchid Chemical
Posted by : MMB MessengerTracked by: 0 Boarder
Orchid Chemicals & Pharmaceuticals Ltd has informed BSE regarding a Press Release dated August 13, 2008 titled "Orchid to develop Novel Anticoagulant Drug Candidate from
Merck"...
52 Week High This month
Posted by :
jipsiTracked by: 0 Boarder
The Management is keen in Buying the stake back from Ranbaxy.
The Ranbaxy group However took the last stake at around 250 on 11th of April. Ranbaxy is not going to sell this golden stake for nothing.
So after the Ranbaxy Deal with Diaachi, we will see the attention to the Orchid Chemicals. Hold the Stock for 2 years, and You will see rich rewards. Read this article for yourself.
Read this Article that came in BS.
Orchid founder may buy back stake from Ranbaxy
S Kalyana Ramanathan / Chennai August 09, 2008, 5:31 IST
K Raghavendra Rao, one of the founding promoters and managing director of Orchid Chemicals and Pharmaceuticals, said he may initiate talks to buy back its 14.7 per cent stake that is now with Rexcel, a unit of pharma major Ranbaxy.
“We may not buy it ourselves, but we can find investors who will be interested in buying it. These could be investors who believe in our vision for the company or like-minded people so to say,” Rao said in an interview with Business Standard.
The negotiations for a possible share buyback may start after Daiichi completes Ranbaxy acquisition. “Let the Ranbaxy-Daiichi deal settle down. We can discuss it after that,” he said.
In the second week of June this year, Japan’s Daiichi Sankyo had agreed to buy controlling interest in Ranbaxy at a possible cost of $3.4-4.6 billion. Rao’s intention to get back 14.7 per cent stake in Orchid from Ranbaxy comes at a time when it is not clear how Daiichi looks at Ranbaxy’s interest in Orchid.
Rao believes that keeping a higher stake among the founding promoters or like-minded investors would help Orchid in clinching its target of becoming a billion-dollar company in the next five years — nearly three times its current size.
The present arrangement with Ranbaxy to supply specific products to access markets across the world stands good, he said. “That is a pure commercial arrangement that we have with any of our customers and partners around the world,” he added.
Rao hopes that future growth for the company is going to come from four important segments – pain management, diabetes, oncology (cancer) and infections. “We should have at least two new molecules by 2010, which can then be licenced to other manufacturers,” he said.
The growth to a billion dollar company is also expected to come with minimum additional investment. “We have done that (investment) already and it has been done only to achieve the billion-dollar vision in the next five years,” Rao said.
...
In reply to:
52 Week High This month
Posted by : venkatagopal
Hi jipsi,
This is great! Do u have any confirmed news? Please comeout with details - it will be of great benefit to the members. 
52 Week High This month
Posted by : venkatagopalTracked by: 0 Boarder
Hi jipsi,
This is great! Do u have any confirmed news? Please comeout with details - it will be of great benefit to the members....
In reply to:
52 Week High This month
Posted by : jipsi
Orchid is ready shoot up to cross 52 weeks high this month.
52 Week High This month
Posted by : jipsiTracked by: 0 Boarder
Orchid is ready shoot up to cross 52 weeks high this month....
1 queries on Orchid Chemical
More from the Pharmaceuticals Sector
see moreBoarders tracking Orchid Chemical
News Updates on Orchid Chemical
Explore Moneycontrol
